Quest Diagnostics Net Worth

Quest Diagnostics Net Worth Analysis

Quest Diagnostics Target Price Consensus

Quest Diagnostics Target Price Projection

Quest Diagnostics' current and average target prices are 166.91 and 183.92, respectively. The current price of Quest Diagnostics is the price at which Quest Diagnostics Incorporated is currently trading. On the other hand, Quest Diagnostics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Quest Diagnostics Incorporated and the information provided on this page.

Know Quest Diagnostics' Top Institutional Investors

Note, although Quest Diagnostics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Quest Diagnostics' market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 18.63 B.

Project Quest Diagnostics' profitablity

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Quest Diagnostics' management efficiency

Quest Diagnostics has Return on Asset of 0.0613 % which means that on every $100 spent on assets, it made $0.0613 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1395 %, implying that it generated $0.1395 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.10 in 2025, whereas Return On Tangible Assets are likely to drop 0.14 in 2025. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.98 in 2025, whereas Total Assets are likely to drop slightly above 8.8 B in 2025.

Quest Diagnostics Corporate Filings

Quest Diagnostics time-series forecasting models is one of many Quest Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Quest Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Quest Diagnostics Earnings Estimation Breakdown

The calculation of Quest Diagnostics' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Quest Diagnostics is estimated to be 2.57 with the future projection ranging from a low of 2.54 to a high of 2.687. Please be aware that this consensus of annual earnings estimates for Quest Diagnostics Incorporated is based on EPS before non-recurring items and includes expenses related to employee stock options.

Quest Diagnostics Earnings Projection Consensus

Quest Diagnostics Earnings History

Earnings estimate consensus by Quest Diagnostics analysts from Wall Street is used by the market to judge Quest Diagnostics' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Quest Diagnostics' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At this time, Quest Diagnostics' Retained Earnings are fairly stable compared to the past year. Earnings Yield is likely to rise to 0.05 in 2025, whereas Retained Earnings Total Equity is likely to drop slightly above 6.6 B in 2025. Common Stock Shares Outstanding is likely to rise to about 126.7 M in 2025, whereas Net Income Applicable To Common Shares is likely to drop slightly above 758.9 M in 2025.

Hype Prediction Low Estimated High 165.29 166.64 167.99 Details

Intrinsic Valuation Low Real High 150.22 177.11 178.46 Details

Naive Forecast Low Next High 164.47 165.82 167.17 Details

19 Analysts Consensus Low Target High 167.37 183.92 204.15 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Quest Diagnostics. Your research has to be compared to or analyzed against Quest Diagnostics' peers to derive any actionable benefits. When done correctly, Quest Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Quest Diagnostics. Note that many institutional investors and large investment bankers can move markets due to the volume of Quest assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Quest Diagnostics. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Quest Diagnostics' stock price in the short term.

Quest Diagnostics Earnings per Share Projection vs Actual

Actual Earning per Share of Quest Diagnostics refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Quest Diagnostics Incorporated predict the company's earnings will be in the future. The higher the earnings per share of Quest Diagnostics, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Quest Diagnostics Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Quest Diagnostics, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Quest Diagnostics should always be considered in relation to other companies to make a more educated investment decision.

Quest Quarterly Analyst Estimates and Surprise Metrics

Quest Diagnostics Corporate Directors

Additional Tools for Quest Stock Analysis